Pavmed Inc (PAVM) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Pavmed Inc   (NASDAQ: PAVM)

Select the Financial Report: Select the Period:


Description of Pavmed Inc's Business Segments


Pavmed Inc. is a medical technology company focused on advancing innovative solutions to various healthcare challenges. The company operates through multiple segments, offering a range of products and services primarily focused on the development of novel medical devices designed to improve patient outcomes while addressing specific clinical needs.

Segments

1. Medical Devices: This segment is the cornerstone of Pavmed’s operations, encompassing a variety of innovative product lines targeting different medical specialties.

2. Digital Health: Pavmed integrates digital solutions to enhance healthcare delivery. This segment focuses on developing software and mobile applications that assist in patient management, data collection, and remote monitoring.

3. Research and Development: Dedicated to innovation, this segment is responsible for the exploration of new technologies and the enhancement of existing products, ensuring the company remains at the forefront of medical device advancements.

4. Commercialization: Once products are developed and tested, Pavmed focuses on strategic marketing and effective distribution channels to introduce products to the market.

Products

1. VivoSight: A pioneering imaging system that uses optical coherence tomography for real-time visualization of tissues. This innovative technology aids in precise diagnostics, guiding surgical intervention, and improving patient outcomes.

2. CarpX: A proprietary device designed for the treatment of carpal tunnel syndrome, CarpX aims to provide a minimally invasive solution that reduces recovery time, lowers costs, and enhances patient satisfaction.

3. DisappEAR: An innovative ear tube designed for pediatric use, DisappEAR is meant to dissolve over time, eliminating the need for surgical removal after serving its purpose in treating otitis media.

4. Next-Generation Laryngeal Mask Airway (LMA): This is developed for airway management in anesthesia, providing a secure airway for patients while minimizing trauma and facilitating ease of use for anesthesiologists.

5. PavMed’s Catheters and Access Devices: A variety of catheter technologies aimed at improving access to veins and arteries, especially for interventions in various surgical fields.

Services

1. Clinical Trials and Studies: Pavmed conducts rigorous clinical trials to validate the safety and efficacy of its products. This service is essential for regulatory approval and gaining acceptance in clinical practice.

2. Consultative Services: Offering expert guidance to healthcare providers, Pavmed delivers consultative services that encompass training on the use of its devices, integration of products into clinical practice, and assistance with implementation strategies.

3. Post-Market Surveillance: After a product is launched, Pavmed engages in ongoing monitoring and assessment to ensure optimal performance in real-world settings and to gather data for potential improvements.

4. Regulatory Support: The company provides technical and regulatory advice to ensure compliance with the strict requirements set forth by regulatory bodies like the FDA.

5. Education and Training Programs: To ensure proper use of devices and to promote best practices, Pavmed provides comprehensive educational resources and training programs for healthcare professionals.

Conclusion

Pavmed Inc. is committed to innovating the medical field through its diverse segments, products, and services. By focusing on patient-centric solutions, the company aims to enhance healthcare delivery and outcomes across various medical disciplines, addressing significant unmet needs in the industry. With a strong emphasis on research and development, Pavmed continues to innovate, providing solutions that bridge the gap between current medical practices and future technologies.


Composition of Pavmed Inc Revenues by Segments

 

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Total 0.03 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Total 135.71 % -36.54 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -6.60 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Pavmed Inc Divisions, Sales by Country

 


Twelve months ended 2025
PAVM s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 0.07 100 %


Twelve months ended 2025
PAVM s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -2.47 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total -97.81 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.